

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.40452686 |
| 2 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25762420 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.18086170 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.18086170 |
| 5 | detection of bacterium (GO:0016045) | 4.16377492 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.16191944 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.16191944 |
| 8 | detection of other organism (GO:0098543) | 4.13358379 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08774702 |
| 10 | negative regulation of cell killing (GO:0031342) | 3.94013823 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.94013823 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.90586959 |
| 13 | protein carboxylation (GO:0018214) | 3.90586959 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.85321020 |
| 15 | response to peptidoglycan (GO:0032494) | 3.83301305 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 3.81155768 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.78224084 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.76673060 |
| 19 | regulation of triglyceride catabolic process (GO:0010896) | 3.74585421 |
| 20 | valine metabolic process (GO:0006573) | 3.74428362 |
| 21 | phospholipid homeostasis (GO:0055091) | 3.74384874 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.71064591 |
| 23 | glyoxylate metabolic process (GO:0046487) | 3.70836507 |
| 24 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69945510 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69400526 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.69400526 |
| 27 | lysine catabolic process (GO:0006554) | 3.61357004 |
| 28 | lysine metabolic process (GO:0006553) | 3.61357004 |
| 29 | pinocytosis (GO:0006907) | 3.59694586 |
| 30 | fatty acid beta-oxidation (GO:0006635) | 3.59441351 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.57758597 |
| 32 | 2-oxoglutarate metabolic process (GO:0006103) | 3.57649067 |
| 33 | cysteine metabolic process (GO:0006534) | 3.53459507 |
| 34 | urea metabolic process (GO:0019627) | 3.52254450 |
| 35 | urea cycle (GO:0000050) | 3.52254450 |
| 36 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.50821287 |
| 37 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.50821287 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50224907 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.50224907 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50224907 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50224907 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50224907 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.50224907 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.49219059 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 3.49219059 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.49219059 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 3.45978590 |
| 48 | regulation of sequestering of triglyceride (GO:0010889) | 3.45431112 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38853467 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37833238 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35179088 |
| 52 | fatty acid oxidation (GO:0019395) | 3.33716691 |
| 53 | positive regulation of lipid catabolic process (GO:0050996) | 3.33656989 |
| 54 | bile acid and bile salt transport (GO:0015721) | 3.31257666 |
| 55 | regulation of protein activation cascade (GO:2000257) | 3.29044916 |
| 56 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.28580824 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.27479641 |
| 58 | lipid oxidation (GO:0034440) | 3.27385025 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.27362190 |
| 60 | nitrogen cycle metabolic process (GO:0071941) | 3.26855618 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25103735 |
| 62 | bile acid biosynthetic process (GO:0006699) | 3.24582043 |
| 63 | fatty acid catabolic process (GO:0009062) | 3.23615252 |
| 64 | positive regulation of fatty acid oxidation (GO:0046321) | 3.22435501 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.22316499 |
| 66 | tryptophan metabolic process (GO:0006568) | 3.20683055 |
| 67 | low-density lipoprotein particle clearance (GO:0034383) | 3.18145060 |
| 68 | regulation of complement activation (GO:0030449) | 3.17685339 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.13621365 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.11704874 |
| 71 | phospholipid efflux (GO:0033700) | 3.11177399 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 3.10742885 |
| 73 | protein localization to endosome (GO:0036010) | 3.08823622 |
| 74 | carnitine metabolic process (GO:0009437) | 3.07765422 |
| 75 | acetyl-CoA metabolic process (GO:0006084) | 3.04725071 |
| 76 | cellular extravasation (GO:0045123) | 3.03783290 |
| 77 | regulation of fatty acid oxidation (GO:0046320) | 3.02473828 |
| 78 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.01668252 |
| 79 | ethanol oxidation (GO:0006069) | 3.00178870 |
| 80 | reverse cholesterol transport (GO:0043691) | 2.98893293 |
| 81 | regulation of water loss via skin (GO:0033561) | 2.94904387 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.94754968 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93993236 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 2.93993236 |
| 85 | macromolecular complex remodeling (GO:0034367) | 2.93993236 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 2.90679195 |
| 87 | negative regulation of sterol transport (GO:0032372) | 2.90679195 |
| 88 | monocarboxylic acid catabolic process (GO:0072329) | 2.89913404 |
| 89 | regulation of cholesterol storage (GO:0010885) | 2.88661099 |
| 90 | serine family amino acid catabolic process (GO:0009071) | 2.88488409 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88480607 |
| 92 | cell-substrate adherens junction assembly (GO:0007045) | 2.88023932 |
| 93 | focal adhesion assembly (GO:0048041) | 2.88023932 |
| 94 | regulation of fibrinolysis (GO:0051917) | 2.87111316 |
| 95 | detection of biotic stimulus (GO:0009595) | 2.86854560 |
| 96 | cellular ketone body metabolic process (GO:0046950) | 2.86332641 |
| 97 | lipoxygenase pathway (GO:0019372) | 2.86227070 |
| 98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.85948519 |
| 99 | tricarboxylic acid metabolic process (GO:0072350) | 2.85774822 |
| 100 | triglyceride homeostasis (GO:0070328) | 2.85207905 |
| 101 | acylglycerol homeostasis (GO:0055090) | 2.85207905 |
| 102 | stress fiber assembly (GO:0043149) | 2.84548047 |
| 103 | cellular modified amino acid catabolic process (GO:0042219) | 2.83543103 |
| 104 | barbed-end actin filament capping (GO:0051016) | 2.82755758 |
| 105 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82530168 |
| 106 | biotin metabolic process (GO:0006768) | 2.82527297 |
| 107 | regulation of cholesterol metabolic process (GO:0090181) | 2.81419171 |
| 108 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.81387367 |
| 109 | carnitine shuttle (GO:0006853) | 2.81009290 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 2.80720605 |
| 111 | ethanol metabolic process (GO:0006067) | 2.79450853 |
| 112 | oxaloacetate metabolic process (GO:0006107) | 2.79375251 |
| 113 | pentose-phosphate shunt (GO:0006098) | 2.79134079 |
| 114 | defense response to fungus (GO:0050832) | 2.79003470 |
| 115 | establishment of skin barrier (GO:0061436) | 2.78564499 |
| 116 | regulation of mast cell degranulation (GO:0043304) | 2.76098686 |
| 117 | primary alcohol catabolic process (GO:0034310) | 2.75621930 |
| 118 | disruption of cells of other organism (GO:0044364) | 2.75282178 |
| 119 | killing of cells of other organism (GO:0031640) | 2.75282178 |
| 120 | cell-substrate junction assembly (GO:0007044) | 2.74241725 |
| 121 | glucose catabolic process (GO:0006007) | 2.74232831 |
| 122 | macrophage activation involved in immune response (GO:0002281) | 2.72414784 |
| 123 | acute-phase response (GO:0006953) | 2.72273569 |
| 124 | bile acid metabolic process (GO:0008206) | 2.72067505 |
| 125 | mannose metabolic process (GO:0006013) | 2.70261445 |
| 126 | regulation of triglyceride metabolic process (GO:0090207) | 2.70022684 |
| 127 | regulation of platelet aggregation (GO:0090330) | 2.69546795 |
| 128 | homocysteine metabolic process (GO:0050667) | 2.69016371 |
| 129 | germinal center formation (GO:0002467) | 2.67429650 |
| 130 | alpha-amino acid catabolic process (GO:1901606) | 2.67314877 |
| 131 | desmosome organization (GO:0002934) | 2.66446385 |
| 132 | cholesterol homeostasis (GO:0042632) | 2.66436981 |
| 133 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.65720066 |
| 134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.65720066 |
| 135 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.65279358 |
| 136 | negative regulation of phagocytosis (GO:0050765) | 2.64880578 |
| 137 | leukocyte aggregation (GO:0070486) | 2.64515994 |
| 138 | adherens junction assembly (GO:0034333) | 2.64448592 |
| 139 | aromatic amino acid family metabolic process (GO:0009072) | 2.63934977 |
| 140 | NADPH regeneration (GO:0006740) | 2.62899061 |
| 141 | positive regulation of lipid storage (GO:0010884) | 2.61201277 |
| 142 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.61074225 |
| 143 | sterol homeostasis (GO:0055092) | 2.60881480 |
| 144 | regulation of gamma-delta T cell activation (GO:0046643) | 2.60667690 |
| 145 | response to host (GO:0075136) | 2.60476404 |
| 146 | response to host defenses (GO:0052200) | 2.60476404 |
| 147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60476404 |
| 148 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.58313522 |
| 149 | keratinization (GO:0031424) | 2.56737729 |
| 150 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55199282 |
| 151 | response to host immune response (GO:0052572) | 2.55199282 |
| 152 | apoptotic process involved in morphogenesis (GO:0060561) | 2.54606237 |
| 153 | angiogenesis involved in wound healing (GO:0060055) | 2.54259666 |
| 154 | detection of molecule of bacterial origin (GO:0032490) | 2.52448144 |
| 155 | response to laminar fluid shear stress (GO:0034616) | 2.51893959 |
| 156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.48591051 |
| 157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48271879 |
| 158 | creatine metabolic process (GO:0006600) | 2.47219508 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46516252 |
| 160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.45531282 |
| 161 | negative regulation of necroptotic process (GO:0060546) | 2.44269242 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.44140608 |
| 163 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.44096102 |
| 164 | hypotonic response (GO:0006971) | 2.41860763 |
| 165 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40996934 |
| 166 | positive regulation of myotube differentiation (GO:0010831) | 2.40180524 |
| 167 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.39247529 |
| 168 | negative regulation of cell size (GO:0045792) | 2.38173344 |
| 169 | regulation of necroptotic process (GO:0060544) | 2.36876082 |
| 170 | muscle filament sliding (GO:0030049) | 2.36426697 |
| 171 | actin-myosin filament sliding (GO:0033275) | 2.36426697 |
| 172 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35652449 |
| 173 | positive regulation of receptor recycling (GO:0001921) | 2.35052190 |
| 174 | * negative regulation of innate immune response (GO:0045824) | 2.33944893 |
| 175 | neutrophil activation (GO:0042119) | 2.32967751 |
| 176 | negative regulation of interleukin-12 production (GO:0032695) | 2.32747934 |
| 177 | COPI coating of Golgi vesicle (GO:0048205) | 2.32529424 |
| 178 | Golgi transport vesicle coating (GO:0048200) | 2.32529424 |
| 179 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32169775 |
| 180 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31483856 |
| 181 | UV protection (GO:0009650) | 2.31002967 |
| 182 | NADH metabolic process (GO:0006734) | 2.30931367 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.30271662 |
| 184 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.30261874 |
| 185 | respiratory burst (GO:0045730) | 2.29373227 |
| 186 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26479130 |
| 187 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.26133233 |
| 188 | regulation of necrotic cell death (GO:0010939) | 2.22967541 |
| 189 | B cell receptor signaling pathway (GO:0050853) | 2.22177504 |
| 190 | granulocyte activation (GO:0036230) | 2.22107690 |
| 191 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21313572 |
| 192 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.20419607 |
| 193 | skin morphogenesis (GO:0043589) | 2.20410142 |
| 194 | regulation of regulated secretory pathway (GO:1903305) | 2.20014175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.58623366 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.24877001 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74490906 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.41681556 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82692302 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.15193968 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91330860 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.71203345 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.65680000 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51579355 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45159952 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33554163 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.30864413 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09858966 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09114673 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03159007 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03004651 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90251559 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81554268 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81217365 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79465548 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76520358 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76049154 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73899580 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73192468 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72422990 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69044551 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64615577 |
| 29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63747059 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61871567 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56600646 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56142259 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55609040 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53820933 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52217139 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52088153 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.51422573 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50867961 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50549931 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50467500 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.50119479 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.48405204 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46281930 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46252039 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46146949 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44918488 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44677005 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44174506 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41060314 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38525634 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.37209316 |
| 52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35568495 |
| 53 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32599349 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32399013 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31832107 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31600113 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31227030 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28362529 |
| 59 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28306890 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28073062 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27943975 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26479059 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25822075 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25793812 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24005183 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22616533 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22614367 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21531039 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21303044 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20694134 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20327353 |
| 72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20263778 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19931676 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19896407 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18620327 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17847222 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17131532 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16501649 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 1.16314803 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16151353 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16151353 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14674598 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14227545 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13390303 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12651927 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12333345 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11517179 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11333318 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11120274 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10760807 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10614357 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10531694 |
| 93 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09695145 |
| 94 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08300217 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.07850662 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07407437 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06672598 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04737375 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03880171 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03715495 |
| 101 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02897891 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02593742 |
| 103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02225604 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02181662 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01768276 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01533013 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01259051 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00849373 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00804916 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00746719 |
| 111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99866539 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99863504 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99449660 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98178754 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98058983 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97912959 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97676116 |
| 118 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97052653 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96230208 |
| 120 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95782273 |
| 121 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95244524 |
| 122 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93357530 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93255638 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 0.91795206 |
| 125 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91119578 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90757442 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90219447 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88817757 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88172013 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87850092 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87802085 |
| 132 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87768466 |
| 133 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87299775 |
| 134 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87211616 |
| 135 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85521293 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84537038 |
| 137 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83744105 |
| 138 | MYB_26560356_Chip-Seq_TH1_Human | 0.83255661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.24931988 |
| 2 | MP0005360_urolithiasis | 4.18391340 |
| 3 | MP0005365_abnormal_bile_salt | 3.12120718 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.11195219 |
| 5 | MP0003303_peritoneal_inflammation | 3.02515215 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.87043006 |
| 7 | MP0009840_abnormal_foam_cell | 2.86794645 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.79542719 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.59417751 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.49780642 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.36609003 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32879298 |
| 13 | MP0004130_abnormal_muscle_cell | 2.29473620 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.23717716 |
| 15 | MP0008260_abnormal_autophagy | 2.18814487 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.05422705 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.96171007 |
| 18 | MP0003436_decreased_susceptibility_to | 1.92601922 |
| 19 | MP0005670_abnormal_white_adipose | 1.84008912 |
| 20 | MP0001849_ear_inflammation | 1.75732097 |
| 21 | MP0005083_abnormal_biliary_tract | 1.72023722 |
| 22 | MP0005501_abnormal_skin_physiology | 1.70494104 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.66354050 |
| 24 | MP0003252_abnormal_bile_duct | 1.65496243 |
| 25 | MP0000609_abnormal_liver_physiology | 1.62210494 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.60229907 |
| 27 | MP0004858_abnormal_nervous_system | 1.58226493 |
| 28 | MP0005332_abnormal_amino_acid | 1.58008198 |
| 29 | MP0000858_altered_metastatic_potential | 1.55795818 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.53930821 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.51573535 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.49520241 |
| 33 | MP0005275_abnormal_skin_tensile | 1.43603954 |
| 34 | MP0001958_emphysema | 1.42848114 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.40827619 |
| 36 | MP0003279_aneurysm | 1.39114277 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.38715449 |
| 38 | MP0002419_abnormal_innate_immunity | 1.33968135 |
| 39 | MP0009785_altered_susceptibility_to | 1.30585497 |
| 40 | MP0002132_abnormal_respiratory_system | 1.29330160 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.29203948 |
| 42 | MP0004947_skin_inflammation | 1.26976722 |
| 43 | MP0001851_eye_inflammation | 1.25376899 |
| 44 | MP0005409_darkened_coat_color | 1.25078798 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.24530437 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.23679814 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.23546698 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.23253515 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.23081684 |
| 50 | MP0004381_abnormal_hair_follicle | 1.22530248 |
| 51 | MP0003724_increased_susceptibility_to | 1.22281012 |
| 52 | MP0005025_abnormal_response_to | 1.21027133 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.20856675 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.20648918 |
| 55 | MP0001873_stomach_inflammation | 1.19353592 |
| 56 | MP0000604_amyloidosis | 1.19309173 |
| 57 | MP0000759_abnormal_skeletal_muscle | 1.18599239 |
| 58 | MP0002796_impaired_skin_barrier | 1.17696730 |
| 59 | MP0000343_altered_response_to | 1.17209142 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.15505201 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.15505201 |
| 62 | MP0003091_abnormal_cell_migration | 1.15142674 |
| 63 | MP0001790_abnormal_immune_system | 1.14268086 |
| 64 | MP0005387_immune_system_phenotype | 1.14268086 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14177658 |
| 66 | MP0002971_abnormal_brown_adipose | 1.13874189 |
| 67 | MP0008469_abnormal_protein_level | 1.13163089 |
| 68 | MP0003195_calcinosis | 1.12457671 |
| 69 | MP0004233_abnormal_muscle_weight | 1.11692917 |
| 70 | MP0005451_abnormal_body_composition | 1.11398821 |
| 71 | MP0003646_muscle_fatigue | 1.10983321 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.10606461 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.10599814 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.08945719 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 1.08449781 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.06670849 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.04329557 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.04212695 |
| 79 | MP0004510_myositis | 1.02894516 |
| 80 | MP0005330_cardiomyopathy | 1.02883231 |
| 81 | MP0009764_decreased_sensitivity_to | 1.01826505 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.01765400 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.00734014 |
| 84 | MP0001800_abnormal_humoral_immune | 1.00672911 |
| 85 | MP0002398_abnormal_bone_marrow | 0.99633165 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.99497312 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.99376511 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.98469585 |
| 89 | MP0008004_abnormal_stomach_pH | 0.98116083 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.97412945 |
| 91 | MP0004036_abnormal_muscle_relaxation | 0.96431295 |
| 92 | MP0004087_abnormal_muscle_fiber | 0.96155726 |
| 93 | MP0003828_pulmonary_edema | 0.96082318 |
| 94 | MP0009931_abnormal_skin_appearance | 0.94375831 |
| 95 | MP0009278_abnormal_bone_marrow | 0.94146945 |
| 96 | MP0000685_abnormal_immune_system | 0.94042047 |
| 97 | MP0003868_abnormal_feces_composition | 0.94006986 |
| 98 | MP0005023_abnormal_wound_healing | 0.93452709 |
| 99 | MP0000751_myopathy | 0.93309307 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.92776686 |
| 101 | MP0002405_respiratory_system_inflammati | 0.91864531 |
| 102 | MP0000750_abnormal_muscle_regeneration | 0.91447839 |
| 103 | MP0003075_altered_response_to | 0.90424876 |
| 104 | MP0004272_abnormal_basement_membrane | 0.89966619 |
| 105 | MP0009763_increased_sensitivity_to | 0.89061062 |
| 106 | MP0000467_abnormal_esophagus_morphology | 0.88134969 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.87020526 |
| 108 | MP0000747_muscle_weakness | 0.86223975 |
| 109 | MP0000598_abnormal_liver_morphology | 0.86120682 |
| 110 | MP0002452_abnormal_antigen_presenting | 0.85998036 |
| 111 | MP0000716_abnormal_immune_system | 0.85662699 |
| 112 | MP0005390_skeleton_phenotype | 0.85571992 |
| 113 | MP0002722_abnormal_immune_system | 0.85409813 |
| 114 | MP0001764_abnormal_homeostasis | 0.85136980 |
| 115 | MP0005000_abnormal_immune_tolerance | 0.84760117 |
| 116 | MP0002269_muscular_atrophy | 0.83767313 |
| 117 | MP0002933_joint_inflammation | 0.82686008 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.82464318 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.81935265 |
| 120 | MP0006138_congestive_heart_failure | 0.81661311 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.81253558 |
| 122 | MP0005334_abnormal_fat_pad | 0.81174810 |
| 123 | MP0002429_abnormal_blood_cell | 0.80951397 |
| 124 | MP0001661_extended_life_span | 0.80337885 |
| 125 | MP0002106_abnormal_muscle_physiology | 0.80047831 |
| 126 | MP0000733_abnormal_muscle_development | 0.79639193 |
| 127 | MP0002723_abnormal_immune_serum | 0.79589050 |
| 128 | MP0000377_abnormal_hair_follicle | 0.79383642 |
| 129 | MP0003186_abnormal_redox_activity | 0.79098385 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.78664123 |
| 131 | MP0001853_heart_inflammation | 0.78564136 |
| 132 | MP0001243_abnormal_dermal_layer | 0.78263045 |
| 133 | MP0000749_muscle_degeneration | 0.77473733 |
| 134 | MP0002060_abnormal_skin_morphology | 0.77369234 |
| 135 | MP0001663_abnormal_digestive_system | 0.75998639 |
| 136 | MP0005671_abnormal_response_to | 0.75707656 |
| 137 | MP0001756_abnormal_urination | 0.74467708 |
| 138 | MP0002420_abnormal_adaptive_immunity | 0.73947092 |
| 139 | MP0001819_abnormal_immune_cell | 0.73852109 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.73654243 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.73642338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.18295348 |
| 2 | Xanthomatosis (HP:0000991) | 4.16786545 |
| 3 | Increased IgE level (HP:0003212) | 3.85864899 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.67767588 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.67364367 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.63792823 |
| 7 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.56812742 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 3.53724422 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.53035848 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.51023058 |
| 11 | Increased variability in muscle fiber diameter (HP:0003557) | 3.37986998 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.37070681 |
| 13 | Complement deficiency (HP:0004431) | 3.33413152 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24858175 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21251600 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 3.19274458 |
| 17 | Joint hemorrhage (HP:0005261) | 3.17496739 |
| 18 | Epidermoid cyst (HP:0200040) | 3.15549381 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.15238148 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.13715562 |
| 21 | Hyperammonemia (HP:0001987) | 3.09343911 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.05130902 |
| 23 | Petechiae (HP:0000967) | 3.03982555 |
| 24 | Ketosis (HP:0001946) | 2.99674898 |
| 25 | Protrusio acetabuli (HP:0003179) | 2.90614988 |
| 26 | Purpura (HP:0000979) | 2.90017839 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.89272858 |
| 28 | Ventricular tachycardia (HP:0004756) | 2.88517423 |
| 29 | Hyperglycinuria (HP:0003108) | 2.86562611 |
| 30 | Vertebral compression fractures (HP:0002953) | 2.85493369 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.84556973 |
| 32 | Myocardial infarction (HP:0001658) | 2.80519554 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.76835188 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.74418181 |
| 35 | Myoglobinuria (HP:0002913) | 2.73388690 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 2.70170534 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.68714551 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.65481034 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.65185004 |
| 40 | Abnormality of complement system (HP:0005339) | 2.63882394 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63688973 |
| 42 | Axonal loss (HP:0003447) | 2.58837848 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58262288 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 2.58262288 |
| 45 | Abnormal platelet volume (HP:0011876) | 2.56843582 |
| 46 | Type 1 muscle fiber predominance (HP:0003803) | 2.54811487 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.53958129 |
| 48 | Difficulty running (HP:0009046) | 2.53834136 |
| 49 | Epistaxis (HP:0000421) | 2.52082924 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.51492047 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.49820077 |
| 52 | Ketoacidosis (HP:0001993) | 2.48312917 |
| 53 | Increased connective tissue (HP:0009025) | 2.47938967 |
| 54 | Esophageal varix (HP:0002040) | 2.47709757 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.46500616 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.45488722 |
| 57 | Cellulitis (HP:0100658) | 2.41257312 |
| 58 | Abnormality of nail color (HP:0100643) | 2.40046975 |
| 59 | Retinal atrophy (HP:0001105) | 2.35730675 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31837117 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.31837117 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.31764177 |
| 63 | Muscle fiber splitting (HP:0003555) | 2.29440884 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.26918648 |
| 65 | Hyperglycinemia (HP:0002154) | 2.26236365 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.23090644 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.22153709 |
| 68 | Obstructive lung disease (HP:0006536) | 2.21714934 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21714934 |
| 70 | Frequent falls (HP:0002359) | 2.21518480 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.20248679 |
| 72 | Rhabdomyolysis (HP:0003201) | 2.19150426 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.18184609 |
| 74 | Round ear (HP:0100830) | 2.16271382 |
| 75 | Sudden death (HP:0001699) | 2.15914845 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.14492466 |
| 77 | Exercise-induced myalgia (HP:0003738) | 2.13931220 |
| 78 | Slender build (HP:0001533) | 2.13582328 |
| 79 | Muscle stiffness (HP:0003552) | 2.13234975 |
| 80 | Mucopolysacchariduria (HP:0008155) | 2.10317783 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10317783 |
| 82 | Premature rupture of membranes (HP:0001788) | 2.07593443 |
| 83 | Myopathic facies (HP:0002058) | 2.06996151 |
| 84 | Ragged-red muscle fibers (HP:0003200) | 2.05350244 |
| 85 | Skin nodule (HP:0200036) | 2.04803154 |
| 86 | Hypercholesterolemia (HP:0003124) | 2.03600766 |
| 87 | Exercise-induced muscle cramps (HP:0003710) | 2.03377853 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02615051 |
| 89 | Cerebral aneurysm (HP:0004944) | 2.00974533 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.00933363 |
| 91 | Bulbar palsy (HP:0001283) | 2.00848778 |
| 92 | Orchitis (HP:0100796) | 1.99294604 |
| 93 | Recurrent skin infections (HP:0001581) | 1.99273478 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.98660172 |
| 95 | Fatigue (HP:0012378) | 1.98340199 |
| 96 | Colitis (HP:0002583) | 1.97971567 |
| 97 | Gingival bleeding (HP:0000225) | 1.97226712 |
| 98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96720945 |
| 99 | Spontaneous hematomas (HP:0007420) | 1.96403284 |
| 100 | Chest pain (HP:0100749) | 1.95938504 |
| 101 | Gout (HP:0001997) | 1.95664843 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 1.93593671 |
| 103 | Neck muscle weakness (HP:0000467) | 1.92199002 |
| 104 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.91888482 |
| 105 | Mitral stenosis (HP:0001718) | 1.91816554 |
| 106 | Menorrhagia (HP:0000132) | 1.91478358 |
| 107 | Spinal rigidity (HP:0003306) | 1.91166397 |
| 108 | Neonatal onset (HP:0003623) | 1.90863713 |
| 109 | Polycythemia (HP:0001901) | 1.90653090 |
| 110 | Peritonitis (HP:0002586) | 1.90485969 |
| 111 | Glomerulonephritis (HP:0000099) | 1.90280179 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90241616 |
| 113 | Inflammation of the large intestine (HP:0002037) | 1.89889869 |
| 114 | Amyloidosis (HP:0011034) | 1.89804439 |
| 115 | Muscle fiber inclusion bodies (HP:0100299) | 1.88859664 |
| 116 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88445425 |
| 117 | Hepatocellular carcinoma (HP:0001402) | 1.87876202 |
| 118 | Fat malabsorption (HP:0002630) | 1.87870019 |
| 119 | Nephritis (HP:0000123) | 1.86823981 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86458299 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86458299 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86458299 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.85963986 |
| 124 | Thin bony cortex (HP:0002753) | 1.84971145 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84048782 |
| 126 | Nemaline bodies (HP:0003798) | 1.83231685 |
| 127 | Urticaria (HP:0001025) | 1.83094945 |
| 128 | Gingivitis (HP:0000230) | 1.82823791 |
| 129 | Dilatation of the ascending aorta (HP:0005111) | 1.80776688 |
| 130 | Pustule (HP:0200039) | 1.79851737 |
| 131 | Myositis (HP:0100614) | 1.79367354 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.79204600 |
| 133 | Hydroxyprolinuria (HP:0003080) | 1.79111153 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 1.79111153 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.78426377 |
| 136 | Recurrent fungal infections (HP:0002841) | 1.78040384 |
| 137 | Late onset (HP:0003584) | 1.78000399 |
| 138 | Vascular calcification (HP:0004934) | 1.77958898 |
| 139 | Autoimmune thrombocytopenia (HP:0001973) | 1.77504653 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.76896793 |
| 141 | Cervical subluxation (HP:0003308) | 1.74378180 |
| 142 | Abnormal platelet function (HP:0011869) | 1.74244903 |
| 143 | Impaired platelet aggregation (HP:0003540) | 1.74244903 |
| 144 | Broad face (HP:0000283) | 1.72662563 |
| 145 | Aneurysm (HP:0002617) | 1.72581640 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.72330771 |
| 147 | Progressive muscle weakness (HP:0003323) | 1.71868816 |
| 148 | Meningitis (HP:0001287) | 1.68795333 |
| 149 | Polygenic inheritance (HP:0010982) | 1.68698724 |
| 150 | Fragile skin (HP:0001030) | 1.68467913 |
| 151 | Blue sclerae (HP:0000592) | 1.67220999 |
| 152 | Easy fatigability (HP:0003388) | 1.67165263 |
| 153 | Aortic aneurysm (HP:0004942) | 1.66848761 |
| 154 | Erythema (HP:0010783) | 1.66645988 |
| 155 | Thick nail (HP:0001805) | 1.66562054 |
| 156 | Generalized amyotrophy (HP:0003700) | 1.65129530 |
| 157 | Hypergammaglobulinemia (HP:0010702) | 1.64927192 |
| 158 | Increased serum ferritin (HP:0003281) | 1.64454233 |
| 159 | Hyperacusis (HP:0010780) | 1.62671493 |
| 160 | Distal arthrogryposis (HP:0005684) | 1.62635094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.12177067 |
| 2 | ERN1 | 4.03135097 |
| 3 | TTN | 3.05315028 |
| 4 | MAP4K1 | 2.98075879 |
| 5 | FGFR4 | 2.94683767 |
| 6 | SIK1 | 2.91216424 |
| 7 | BCKDK | 2.84500813 |
| 8 | SMG1 | 2.80520879 |
| 9 | PKN2 | 2.72746068 |
| 10 | PRPF4B | 2.46123380 |
| 11 | RIPK1 | 2.37599549 |
| 12 | EPHB1 | 2.11847219 |
| 13 | MAP2K3 | 1.95458625 |
| 14 | TYK2 | 1.85981885 |
| 15 | TGFBR2 | 1.71675467 |
| 16 | PIK3CA | 1.65542389 |
| 17 | IRAK3 | 1.63030739 |
| 18 | PTK6 | 1.57860005 |
| 19 | EEF2K | 1.56910775 |
| 20 | TNK2 | 1.51618131 |
| 21 | ICK | 1.48979050 |
| 22 | TBK1 | 1.45278637 |
| 23 | MAP3K6 | 1.41603283 |
| 24 | KDR | 1.39791560 |
| 25 | TAOK3 | 1.38577312 |
| 26 | PRKD2 | 1.38062027 |
| 27 | BLK | 1.34151280 |
| 28 | TAOK1 | 1.32174352 |
| 29 | GRK6 | 1.30911454 |
| 30 | MAP3K7 | 1.28241184 |
| 31 | CDK12 | 1.27532173 |
| 32 | JAK1 | 1.27299105 |
| 33 | FES | 1.27010749 |
| 34 | CAMK1D | 1.26930028 |
| 35 | MYLK | 1.24243730 |
| 36 | TAOK2 | 1.23447353 |
| 37 | CSF1R | 1.22458902 |
| 38 | JAK3 | 1.22340978 |
| 39 | ZAP70 | 1.18561026 |
| 40 | CSK | 1.17717905 |
| 41 | CAMK1G | 1.17188478 |
| 42 | STK10 | 1.16268652 |
| 43 | FGFR3 | 1.13004693 |
| 44 | KIT | 1.12290296 |
| 45 | LRRK2 | 1.10890263 |
| 46 | MARK2 | 1.10665853 |
| 47 | DMPK | 1.10137891 |
| 48 | MAP3K3 | 1.09791200 |
| 49 | FLT3 | 1.09722669 |
| 50 | ITK | 1.04027244 |
| 51 | TESK2 | 1.01591988 |
| 52 | MAPKAPK3 | 0.97961714 |
| 53 | TIE1 | 0.97847977 |
| 54 | HCK | 0.97376272 |
| 55 | PIK3CG | 0.93627510 |
| 56 | BTK | 0.93462339 |
| 57 | NEK9 | 0.93327319 |
| 58 | CDC42BPA | 0.93305061 |
| 59 | JAK2 | 0.89869227 |
| 60 | FGFR2 | 0.89020027 |
| 61 | ARAF | 0.88117382 |
| 62 | PDGFRA | 0.87654050 |
| 63 | BMX | 0.87309462 |
| 64 | TESK1 | 0.84671030 |
| 65 | MAPK11 | 0.83894709 |
| 66 | KSR2 | 0.83890472 |
| 67 | RIPK4 | 0.83341424 |
| 68 | FGR | 0.82561997 |
| 69 | CDK9 | 0.80967800 |
| 70 | MAP3K14 | 0.79756471 |
| 71 | TRPM7 | 0.79470686 |
| 72 | LMTK2 | 0.78689119 |
| 73 | EPHA3 | 0.78402490 |
| 74 | IRAK4 | 0.77163651 |
| 75 | IRAK2 | 0.77118729 |
| 76 | MATK | 0.75429495 |
| 77 | FER | 0.72572170 |
| 78 | MAP3K11 | 0.71973997 |
| 79 | DYRK1B | 0.69963577 |
| 80 | MARK3 | 0.69786689 |
| 81 | FRK | 0.68290657 |
| 82 | OBSCN | 0.67078668 |
| 83 | MAP2K6 | 0.66638330 |
| 84 | PTK2 | 0.66197155 |
| 85 | MAP3K1 | 0.66019713 |
| 86 | MST1R | 0.65590134 |
| 87 | MTOR | 0.65533448 |
| 88 | SYK | 0.64719715 |
| 89 | PRKAA2 | 0.63229802 |
| 90 | PDPK1 | 0.62917470 |
| 91 | HIPK2 | 0.62740842 |
| 92 | MAP3K13 | 0.62724580 |
| 93 | SGK3 | 0.62174711 |
| 94 | EPHA2 | 0.60610698 |
| 95 | IKBKE | 0.60384893 |
| 96 | PRKCH | 0.58818720 |
| 97 | RET | 0.58705484 |
| 98 | MAP3K10 | 0.58256261 |
| 99 | PRKD1 | 0.57120536 |
| 100 | CDK4 | 0.54035278 |
| 101 | MAPK7 | 0.53535875 |
| 102 | MAPK4 | 0.52986358 |
| 103 | MAP3K8 | 0.52984617 |
| 104 | PIM2 | 0.52075694 |
| 105 | MAP2K4 | 0.51984739 |
| 106 | STK38 | 0.51347883 |
| 107 | MAP2K2 | 0.51069426 |
| 108 | MAPK12 | 0.50274619 |
| 109 | PAK4 | 0.49279760 |
| 110 | RPS6KL1 | 0.48839842 |
| 111 | RPS6KC1 | 0.48839842 |
| 112 | IRAK1 | 0.48513872 |
| 113 | TEC | 0.48174400 |
| 114 | RPS6KA6 | 0.47054105 |
| 115 | PDK1 | 0.46826050 |
| 116 | MAP3K5 | 0.45997119 |
| 117 | MAPKAPK2 | 0.45647649 |
| 118 | SIK3 | 0.44646031 |
| 119 | PHKG2 | 0.44145143 |
| 120 | PHKG1 | 0.44145143 |
| 121 | NME2 | 0.43747282 |
| 122 | IKBKB | 0.43194957 |
| 123 | RPS6KA4 | 0.42795224 |
| 124 | RPS6KA2 | 0.41090300 |
| 125 | CHUK | 0.40706446 |
| 126 | ABL2 | 0.40428526 |
| 127 | ILK | 0.38739788 |
| 128 | PRKD3 | 0.38463750 |
| 129 | PRKG2 | 0.38326062 |
| 130 | LYN | 0.38322930 |
| 131 | LCK | 0.38289111 |
| 132 | PRKACG | 0.38063734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09380838 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.03134331 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89564681 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56209685 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.55532770 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41368756 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39208010 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34488736 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31187495 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28669621 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.27507587 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27504768 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24146739 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22140646 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18653653 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07017412 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90275225 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85353043 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81294428 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.77229877 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77091531 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66652577 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65894717 |
| 24 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.65426992 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65270496 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.63192324 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51884060 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.49379357 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48603136 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47979008 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45630089 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42760289 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42401214 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42304955 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39734483 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37576784 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36194562 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.34020079 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29332509 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29061738 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.21529823 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21179645 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14265046 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.13877526 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13429214 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 1.11237704 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09870976 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08753300 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07416978 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05711499 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05059164 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03050004 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99017600 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98082481 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97647858 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97097398 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95326699 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94151590 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.94084171 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94074753 |
| 61 | * Influenza A_Homo sapiens_hsa05164 | 0.93805314 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93544249 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91870296 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.91811530 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91719617 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.91244917 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.90456031 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89726201 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.87869017 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86623216 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86544081 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85858959 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85541015 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84794421 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84296292 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84154712 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.83241240 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83021718 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82915003 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82889004 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82514641 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.79453407 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78447741 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78029069 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78028602 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77106157 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77060715 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76343550 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75592805 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75017395 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74957646 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74514965 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74076721 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73965704 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73673608 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73355086 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.72917220 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72875681 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.72716277 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71601830 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71338094 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71063956 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70413889 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70356911 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70349395 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69000002 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.68349969 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67818885 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.66623790 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66495680 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66077037 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65395393 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65261210 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64973603 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64758519 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63801604 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62970523 |
| 118 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61025047 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59935416 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59922132 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57287397 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57073319 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55799856 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.54264002 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.53059075 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52373113 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50016647 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.45304353 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44356905 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.42761106 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42047164 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40935508 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40116319 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39799918 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39325233 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.38473481 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38004074 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37010333 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36700641 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.32157942 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31721835 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30336293 |
| 143 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29978525 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.23964915 |
| 145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23790489 |
| 146 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.23437227 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22641447 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22527418 |
| 149 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.22298099 |
| 150 | Malaria_Homo sapiens_hsa05144 | 0.21798580 |
| 151 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21476125 |
| 152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21150851 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20752109 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.20622656 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19212094 |
| 156 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.18982779 |

